These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34350132)

  • 21. Metalloproteinases and their inhibitors are associated with pulmonary arterial stiffness and ventricular function in pediatric pulmonary hypertension.
    Schäfer M; Ivy DD; Nguyen K; Boncella K; Frank BS; Morgan GJ; Miller-Reed K; Truong U; Colvin K; Yeager ME
    Am J Physiol Heart Circ Physiol; 2021 Jul; 321(1):H242-H252. PubMed ID: 34085841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.
    Ulrich D; Lichtenegger F; Eblenkamp M; Repper D; Pallua N
    Plast Reconstr Surg; 2004 Jul; 114(1):229-36. PubMed ID: 15220598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases in isolated hypercholesterolemia.
    Malik J; Stulc T; Ceska R
    Int Angiol; 2005 Sep; 24(3):300-3. PubMed ID: 16158043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interplay of angiotensin II and angiotensin(1-7) in the regulation of matrix metalloproteinases of human cardiocytes.
    Pan CH; Wen CH; Lin CS
    Exp Physiol; 2008 May; 93(5):599-612. PubMed ID: 18296491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.
    Dietmann A; Helbok R; Lackner P; Issifou S; Lell B; Matsiegui PB; Reindl M; Schmutzhard E; Kremsner PG
    J Infect Dis; 2008 Jun; 197(11):1614-20. PubMed ID: 18700258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum profiles of matrix metalloproteinases and their tissue inhibitors in long-term pulmonary complication induced by sulfur mustard: Sardasht-Iran Cohort Study (SICS).
    Kiani A; Mostafaie A; Shirazi FH; Ghazanfari T
    Int Immunopharmacol; 2013 Nov; 17(3):964-7. PubMed ID: 23370298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase levels in chronic thoracic aortic dissection.
    Zhang X; Wu D; Choi JC; Minard CG; Hou X; Coselli JS; Shen YH; LeMaire SA
    J Surg Res; 2014 Jun; 189(2):348-58. PubMed ID: 24746253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
    Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
    Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations Between MMPs and TIMPs Levels in Aqueous Humor from High Myopia and Cataract Patients.
    Jia Y; Hu DN; Sun J; Zhou J
    Curr Eye Res; 2017 Apr; 42(4):600-603. PubMed ID: 28402202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating matrix metalloproteinases and their inhibitors in patients with Kawasaki disease.
    Senzaki H; Masutani S; Kobayashi J; Kobayashi T; Nakano H; Nagasaka H; Sasaki N; Asano H; Kyo S; Yokote Y
    Circulation; 2001 Aug; 104(8):860-3. PubMed ID: 11514369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinases and their inhibitors in Fuchs endothelial corneal dystrophy.
    Xu I; Thériault M; Brunette I; Rochette PJ; Proulx S
    Exp Eye Res; 2021 Apr; 205():108500. PubMed ID: 33617849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma profiles of matrix metalloproteinases and tissue inhibitors of the metalloproteinases predict recurrence of atrial fibrillation following cardioversion.
    Mukherjee R; Akar JG; Wharton JM; Adams DK; McClure CD; Stroud RE; Rice AD; DeSantis SM; Spinale FG; Gold MR
    J Cardiovasc Transl Res; 2013 Aug; 6(4):528-35. PubMed ID: 23722357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alternate perspective on the roles of TIMPs and MMPs in pathology.
    Moore CS; Crocker SJ
    Am J Pathol; 2012 Jan; 180(1):12-6. PubMed ID: 22033229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip joints.
    Takei I; Takagi M; Santavirta S; Ida H; Hamasaki M; Ishii M; Fukushima S; Ogino T; Konttinen YT
    J Biomed Mater Res; 1999 Jun; 45(3):175-83. PubMed ID: 10397973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis.
    Noji Y; Kajinami K; Kawashiri MA; Todo Y; Horita T; Nohara A; Higashikata T; Inazu A; Koizumi J; Takegoshi T; Mabuchi H
    Clin Chem Lab Med; 2001 May; 39(5):380-4. PubMed ID: 11434385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.
    Herszényi L; Hritz I; Lakatos G; Varga MZ; Tulassay Z
    Int J Mol Sci; 2012 Oct; 13(10):13240-63. PubMed ID: 23202950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.
    Vianello A; Caponi L; Franzoni F; Galetta F; Rossi M; Taddei M; Malvaldi G; Pietrini P; Santoro G
    Clin Sci (Lond); 2009 Jul; 117(4):157-64. PubMed ID: 19196241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathy.
    Essa EM; Zile MR; Stroud RE; Rice A; Gumina RJ; Leier CV; Spinale FG
    J Card Fail; 2012 Jun; 18(6):487-92. PubMed ID: 22633307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathy.
    Vandooren B; Kruithof E; Yu DT; Rihl M; Gu J; De Rycke L; Van Den Bosch F; Veys EM; De Keyser F; Baeten D
    Arthritis Rheum; 2004 Sep; 50(9):2942-53. PubMed ID: 15457463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.